Entero Therapeutics to Change Name to GridAI and Switch Ticker to GRDX, Shares Rise 5%

Entero Therapeutics' stock rose 5.28% to $2.99 after the company announced a name change to GridAI Technologies Corp. and ticker change to GRDX, effective December 1, 2025, following its acquisition of an AI-driven grid-edge software business. GridAI develops software for utilities and large power users to manage distributed energy resources and demand in real time. The name change reflects a strategic pivot from GI-disease focus to AI-powered energy infrastructure.